BY TYLER DURDENFRIDAY, AUG 06, 2021 – 02:45 AM
Over 190 million people have officially contracted SARS-CoV-2, the virus which causes Covid-19. Of that, the vast majority have recovered – while up to one-third reportedly suffer from lingering symptoms of varying severity, known as ‘long covid.’
Common complaints include a lack of smell and taste, as well as “brain fog” – in which sufferers often complain of ongoing confusion, lack of focus, and migraines – well after they’ve ‘recovered’ from the disease.
Last week, The Independent reported that Covid-19 may accelerate the onset of Alzheimer’s disease in patients suffering from neurological symptoms, while another study noted in the report found that coronavirus patients “are more susceptible to long-term memory and thinking problems.”
Last September, a study offered the first clear evidence that Covid-19 ‘hijacks’ brain cells to make copies of itself – starving nearby cells of oxygen. The same researchers found last July that some Covid-19 patients have developed serious neurological complications, including nerve damage.
Now, a large-scale study in the UK of more than 80,000 participants “offers convincing evidence that COVID-19 may indeed result in long-term cognitive deficits – even in those who suffer the mildest form of the disease,” according to Dr. Rhonda Patrick.
Meanwhile, Patrick also points to a different study which found a significant loss in grey matter.
Bret Weinstein brings up an excellent, carefully-worded point in response to the above, tweeting: “it’s vital to determine how the emergence of cognitive deficits interact with early interventions and preventive measures.
“A terrible development. Assuming the result holds up, it’s vital to determine how the emergence of cognitive deficits interact with early interventions and preventive measures. Sending people with Covid home to sicken in place (and to sicken others) never made sense.”
Dr. Rhonda Patrick @foundmyfitness: A new large-scale study including 81,337 UK participants offers convincing evidence that COVID-19 may indeed result in long-term cognitive deficits – even in those who suffer the mildest form of the disease.
Indeed, would early intervention with, say, Ivermectin, impact these findings?